The Microelisa stripplate provided in this kit has been pre-coated with an antibody specific to GLP1
Suspected adverse reactions or product quality concerns must be reported via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk
for their use in eye irritation in Tanzania [342]
This research was financially supported by National Natural Science Foundation of China (81874255), Science and Technology Department of Sichuan Province (2021YJ0194, 2023JDRC0019, 2022ZYD0091) and Health Commission of Sichuan Province (21ZD008, 2023-802), Cadres Health Scientific Project of Sichuan Province (2021-803) and Sichuan Cancer Hospital Research Program (YB2023015, YBR2019003, YB2021023)
The label expansion was supported by data from the Phase III ASC4FIRST study, in which 68% of patients treated with Scemblix achieved a major molecular response compared with 49% of those treated with standard-of-care tyrosine kinase inhibitors, including imatinib and nilotinib
Long-acting insulin should be the initial choice in early insulin intervention in patients with LADA
